David Maloney

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Procedures

Disorders

Concepts & Ideas

Chemicals & Drugs

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Gyurkocza Boglarka; Cao Thai M; Storb Rainer F; Lange Thoralf; Leisenring Wendy; Franke Georg N; Sorror Mohamed; Hoppe Richard; Maloney David G; Negrin Robert S; Shizuru Judith A; Sandmaier Brenda M
Salvage allogeneic hematopoietic cell transplantation with fludarabine and low-dose total body irradiation after rejection of first allografts.
Nakamae Hirohisa; Kirby Katharine A; Sandmaier Brenda M; Norasetthada Lalita; Maloney David G; Maris Michael B; Davis Chris; Corey Lawrence; Storb Rainer; Boeckh Michael
Effect of conditioning regimen intensity on CMV infection in allogeneic hematopoietic cell transplantation.
Baron Frédéric; Petersdorf Effie W; Gooley Ted; Sandmaier Brenda M; Malkki Mari; Chauncey Thomas R; Maloney David G; Storb Rainer
What is the role for donor natural killer cells after nonmyeloablative conditioning?

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of David Maloney (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Gyurkocza Boglarka; Cao Thai M; Storb Rainer F; Lange Thoralf; Leisenring Wendy; Franke Georg N; Sorror Mohamed; Hoppe Richard; Maloney David G; Negrin Robert S; Shizuru Judith A; Sandmaier Brenda M
Salvage allogeneic hematopoietic cell transplantation with fludarabine and low-dose total body irradiation after rejection of first allografts.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2009;15(10):1314-22.
2009: Nakamae Hirohisa; Kirby Katharine A; Sandmaier Brenda M; Norasetthada Lalita; Maloney David G; Maris Michael B; Davis Chris; Corey Lawrence; Storb Rainer; Boeckh Michael
Effect of conditioning regimen intensity on CMV infection in allogeneic hematopoietic cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2009;15(6):694-703.
2009: Baron Frédéric; Petersdorf Effie W; Gooley Ted; Sandmaier Brenda M; Malkki Mari; Chauncey Thomas R; Maloney David G; Storb Rainer
What is the role for donor natural killer cells after nonmyeloablative conditioning?
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2009;15(5):580-8.
2009: Rotta Marcello; Storer Barry E; Sahebi Firoozeh; Shizuru Judith A; Bruno Benedetto; Lange Thoralf; Agura Edward D; McSweeney Peter A; Pulsipher Michael A; Hari Parameswaran; Maziarz Richard T; Chauncey Thomas R; Appelbaum Frederick R; Sorror Mohamed L; Bensinger William; Sandmaier Brenda M; Storb Rainer F; Maloney David G
Long-term outcome of patients with multiple myeloma after autologous hematopoietic cell transplantation and nonmyeloablative allografting.
Blood 2009;113(14):3383-91.
2008: Storek Jan; Zhao Zhao; Liu Yiping; Nash Richard; McSweeney Peter; Maloney David G
Early recovery of CD4 T cell receptor diversity after "lymphoablative" conditioning and autologous CD34 cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2008;14(12):1373-9.
2008: Burroughs Lauri M; O'Donnell Paul V; Sandmaier Brenda M; Storer Barry E; Luznik Leo; Symons Heather J; Jones Richard J; Ambinder Richard F; Maris Michael B; Blume Karl G; Niederwieser Dietger W; Bruno Benedetto; Maziarz Richard T; Pulsipher Michael A; Petersen Finn B; Storb Rainer; Fuchs Ephraim J; Maloney David G
Comparison of outcomes of HLA-matched related, unrelated, or HLA-haploidentical related hematopoietic cell transplantation following nonmyeloablative conditioning for relapsed or refractory Hodgkin lymphoma.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2008;14(11):1279-87.
2008: Rezvani Andrew R; Norasetthada Lalitha; Gooley Ted; Sorror Mohamed; Bouvier Michelle E; Sahebi Firoozeh; Agura Edward; Chauncey Thomas; Maziarz Richard T; Maris Michael; Shizuru Judith; Bruno Benedetto; Bredeson Christopher; Lange Thoralf; Yeager Andrew; Sandmaier Brenda M; Storb Rainer F; Maloney David G
Non-myeloablative allogeneic haematopoietic cell transplantation for relapsed diffuse large B-cell lymphoma: a multicentre experience.
British journal of haematology 2008;143(3):395-403.
2008: Sorror Mohamed L; Storer Barry E; Sandmaier Brenda M; Maris Michael; Shizuru Judith; Maziarz Richard; Agura Edward; Chauncey Thomas R; Pulsipher Michael A; McSweeney Peter A; Wade James C; Bruno Benedetto; Langston Amelia; Radich Jerald; Niederwieser Dietger; Blume Karl G; Storb Rainer; Maloney David G
Five-year follow-up of patients with advanced chronic lymphocytic leukemia treated with allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(30):4912-20.
2008: Gopal Ajay K; Metcalfe Tracee L; Gooley Ted A; Pagel John M; Petersdorf Stephen H; Bensinger William I; Holmberg Leona; Maloney David G; Press Oliver W
High-dose therapy and autologous stem cell transplantation for chemoresistant Hodgkin lymphoma: the Seattle experience.
Cancer 2008;113(6):1344-50.
2008: Gopal Ajay K; Press Oliver W; Wilbur Shani M; Maloney David G; Pagel John M
Rituximab blocks binding of radiolabeled anti-CD20 antibodies (Ab) but not radiolabeled anti-CD45 Ab.
Blood 2008;112(3):830-5.
2008: Till Brian G; Gooley Theodore A; Crawford Nathan; Gopal Ajay K; Maloney David G; Petersdorf Stephen H; Pagel John M; Holmberg Leona; Bensinger William; Press Oliver W
Effect of remission status and induction chemotherapy regimen on outcome of autologous stem cell transplantation for mantle cell lymphoma.
Leukemia & lymphoma 2008;49(6):1062-73.
2008: Sorror Mohamed; Storer Barry; Sandmaier Brenda M; Maloney David G; Chauncey Thomas R; Langston Amelia; Maziarz Richard T; Pulsipher Michael; McSweeney Peter A; Storb Rainer
Hematopoietic cell transplantation-comorbidity index and Karnofsky performance status are independent predictors of morbidity and mortality after allogeneic nonmyeloablative hematopoietic cell transplantation.
Cancer 2008;112(9):1992-2001.
2008: Laport Ginna G; Sandmaier Brenda M; Storer Barry E; Scott Bart L; Stuart Monic J; Lange Thoralf; Maris Michael B; Agura Edward D; Chauncey Thomas R; Wong Ruby M; Forman Stephen J; Petersen Finn B; Wade James C; Epner Elliot; Bruno Benedetto; Bethge Wolfgang A; Curtin Peter T; Maloney David G; Blume Karl G; Storb Rainer F
Reduced-intensity conditioning followed by allogeneic hematopoietic cell transplantation for adult patients with myelodysplastic syndrome and myeloproliferative disorders.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2008;14(2):246-55.
2008: Maloney David G
What is the role of maintenance rituximab in follicular NHL?
Oncology (Williston Park, N.Y.) 2008;22(1):20-6; discussion 26, 29, 33-4.
2008: Rezvani Andrew R; Storer Barry; Maris Michael; Sorror Mohamed L; Agura Edward; Maziarz Richard T; Wade James C; Chauncey Thomas; Forman Stephen J; Lange Thoralf; Shizuru Judith; Langston Amelia; Pulsipher Michael A; Sandmaier Brenda M; Storb Rainer; Maloney David G
Nonmyeloablative allogeneic hematopoietic cell transplantation in relapsed, refractory, and transformed indolent non-Hodgkin's lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(2):211-7.
2008: Sorror Mohamed L; Storer Barry E; Maloney David G; Sandmaier Brenda M; Martin Paul J; Storb Rainer
Outcomes after allogeneic hematopoietic cell transplantation with nonmyeloablative or myeloablative conditioning regimens for treatment of lymphoma and chronic lymphocytic leukemia.
Blood 2008;111(1):446-52.
2007: Mielcarek Marco; Storer Barry E; Sandmaier Brenda M; Sorror Mohamed L; Maloney David G; Petersdorf Effie; Martin Paul J; Storb Rainer
Comparable outcomes after nonmyeloablative hematopoietic cell transplantation with unrelated and related donors.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2007;13(12):1499-507.
2007: Pham R N; Gooley T A; Keeney G E; Press O W; Pagel J M; Greisman H A; Bensinger W I; Holmberg L A; Petersdorf S H; Maloney D G; Gopal A K
The impact of histologic grade on the outcome of high-dose therapy and autologous stem cell transplantation for follicular lymphoma.
Bone marrow transplantation 2007;40(11):1039-44.
2007: Sorror Mohamed L; Giralt Sergio; Sandmaier Brenda M; De Lima Marcos; Shahjahan Munir; Maloney David G; Deeg H Joachim; Appelbaum Frederick R; Storer Barry; Storb Rainer
Hematopoietic cell transplantation specific comorbidity index as an outcome predictor for patients with acute myeloid leukemia in first remission: combined FHCRC and MDACC experiences.
Blood 2007;110(13):4606-13.
2007: Keeney Grant E; Gooley Ted A; Pham Rosalyn N; Press Oliver W; Pagel John M; Petersdorf Stephen H; Maloney David G; Bensinger William; Holmberg Leona; Gopal Ajay K
The pretransplant Follicular Lymphoma International Prognostic Index is associated with survival of follicular lymphoma patients undergoing autologous hematopoietic stem cell transplantation.
Leukemia & lymphoma 2007;48(10):1961-7.
2007: Kahl Christoph; Storer Barry E; Sandmaier Brenda M; Mielcarek Marco; Maris Michael B; Blume Karl G; Niederwieser Dietger; Chauncey Thomas R; Forman Stephen J; Agura Edward; Leis Jose F; Bruno Benedetto; Langston Amelia; Pulsipher Michael A; McSweeney Peter A; Wade James C; Epner Elliot; Bo Petersen Finn; Bethge Wolfgang A; Maloney David G; Storb Rainer
Relapse risk in patients with malignant diseases given allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning.
Blood 2007;110(7):2744-8.
2007: Sorror Mohamed L; Sandmaier Brenda M; Storer Barry E; Maris Michael B; Baron Frédéric; Maloney David G; Scott Bart L; Deeg H Joachim; Appelbaum Frederick R; Storb Rainer
Comorbidity and disease status based risk stratification of outcomes among patients with acute myeloid leukemia or myelodysplasia receiving allogeneic hematopoietic cell transplantation.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(27):4246-54.
2007: Baron Frédéric; Sandmaier Brenda M; Storer Barry E; Maris Michael B; Langston Amelia A; Lange Thoralf; Petersdorf Effie; Bethge Wolfgang; Maziarz Richard T; McSweeney Peter A; Pulsipher Michael A; Wade James C; Chauncey Thomas R; Shizuru Judith A; Sorror Mohamed L; Woolfrey Ann E; Maloney David G; Storb Rainer
Extended mycophenolate mofetil and shortened cyclosporine failed to reduce graft-versus-host disease after unrelated hematopoietic cell transplantation with nonmyeloablative conditioning.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2007;13(9):1041-8.
2007: Gopal Ajay K; Rajendran Joseph G; Gooley Ted A; Pagel John M; Fisher Darrell R; Petersdorf Stephen H; Maloney David G; Eary Janet F; Appelbaum Frederick R; Press Oliver W
High-dose [131I]tositumomab (anti-CD20) radioimmunotherapy and autologous hematopoietic stem-cell transplantation for adults > or = 60 years old with relapsed or refractory B-cell lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(11):1396-402.
2007: Georges George E; Maris Michael B; Maloney David G; Sandmaier Brenda M; Sorror Mohamed L; Shizuru Judith A; Lange Thoralf; Agura Edward D; Bruno Benedetto; McSweeney Peter A; Pulsipher Michael A; Chauncey Thomas R; Mielcarek Marco; Storer Barry E; Storb Rainer
Nonmyeloablative unrelated donor hematopoietic cell transplantation to treat patients with poor-risk, relapsed, or refractory multiple myeloma.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2007;13(4):423-32.
2006: Baron Frédéric; Storer Barry; Maris Michael B; Storek Jan; Piette Fanny; Metcalf Monja; White Kristen; Sandmaier Brenda M; Maloney David G; Storb Rainer; Boeckh Michael
Unrelated donor status and high donor age independently affect immunologic recovery after nonmyeloablative conditioning.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2006;12(11):1176-87.
2006: Press Oliver W; Unger Joseph M; Braziel Rita M; Maloney David G; Miller Thomas P; Leblanc Michael; Fisher Richard I;
Phase II trial of CHOP chemotherapy followed by tositumomab/iodine I-131 tositumomab for previously untreated follicular non-Hodgkin's lymphoma: five-year follow-up of Southwest Oncology Group Protocol S9911.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(25):4143-9.
2006: Baron Frédéric; Storb Rainer; Storer Barry E; Maris Michael B; Niederwieser Dietger; Shizuru Judith A; Chauncey Thomas R; Bruno Benedetto; Forman Stephen J; McSweeney Peter A; Maziarz Richard T; Pulsipher Michael A; Agura Edward D; Wade James; Sorror Mohamed; Maloney David G; Sandmaier Brenda M
Factors associated with outcomes in allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning after failed myeloablative hematopoietic cell transplantation.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(25):4150-7.
2006: Gopal Ajay K; Pagel John M; Rajendran Joseph G; Maloney David G; Appelbaum Frederick R; Sorror Mohamed L; Sandmaier Brenda M; Storb Rainer; Press Oliver W
Improving the efficacy of reduced intensity allogeneic transplantation for lymphoma using radioimmunotherapy.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2006;12(7):697-702.
2006: Lilleby K; Garcia P; Gooley T; McDonnnell P; Taber R; Holmberg L; Maloney D G; Press O W; Bensinger W
A prospective, randomized study of cryotherapy during administration of high-dose melphalan to decrease the severity and duration of oral mucositis in patients with multiple myeloma undergoing autologous peripheral blood stem cell transplantation.
Bone marrow transplantation 2006;37(11):1031-5.
2006: Maris Michael B; Sandmaier Brenda M; Storer Barry E; Maloney David G; Shizuru Judith A; Agura Edward; Kliem Constanze; Pulsipher Michael; Maziarz Richard T; McSweeney Peter A; Wade James; Langston Amelia A; Chauncey Thomas R; Bruno Benedetto; Blume Karl G; Storb Rainer
Unrelated donor granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cell transplantation after nonmyeloablative conditioning: the effect of postgrafting mycophenolate mofetil dosing.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2006;12(4):454-65.
2006: Burroughs Lauri; Mielcarek Marco; Leisenring Wendy; Sandmaier Brenda M; Maloney David G; Baron Frédéric; Martin Paul J; Flowers Mary E D; Forman Stephen J; Chauncey Thomas R; Bruno Benedetto; Storb Rainer
Extending postgrafting cyclosporine decreases the risk of severe graft-versus-host disease after nonmyeloablative hematopoietic cell transplantation.
Transplantation 2006;81(6):818-25.
2006: Scott B L; Sandmaier B M; Storer B; Maris M B; Sorror M L; Maloney D G; Chauncey T R; Storb R; Deeg H J
Myeloablative vs nonmyeloablative allogeneic transplantation for patients with myelodysplastic syndrome or acute myelogenous leukemia with multilineage dysplasia: a retrospective analysis.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2006;20(1):128-35.
2006: Zaucha Renata E; Buckner Dean C; Barnett Todd; Holmberg Leona A; Gooley Ted; Hooper Heather A; Maloney David G; Appelbaum Frederick; Bensinger William I
Modified total body irradiation as a planned second high-dose therapy with stem cell infusion for patients with bone-based malignancies.
International journal of radiation oncology, biology, physics 2006;64(1):227-34.
2005: Sorror Mohamed L; Maris Michael B; Storb Rainer; Baron Frederic; Sandmaier Brenda M; Maloney David G; Storer Barry
Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT.
Blood 2005;106(8):2912-9.
2005: Maloney David G
Immunotherapy for non-Hodgkin's lymphoma: monoclonal antibodies and vaccines.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(26):6421-8.
2005: Sorror Mohamed L; Maris Michael B; Sandmaier Brenda M; Storer Barry E; Stuart Monic J; Hegenbart Ute; Agura Edward; Chauncey Thomas R; Leis Jose; Pulsipher Michael; McSweeney Peter; Radich Jerald P; Bredeson Christopher; Bruno Benedetto; Langston Amelia; Loken Michael R; Al-Ali Haifa; Blume Karl G; Storb Rainer; Maloney David G
Hematopoietic cell transplantation after nonmyeloablative conditioning for advanced chronic lymphocytic leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(16):3819-29.
2005: Kerbauy F R; Storb R; Hegenbart U; Gooley T; Shizuru J; Al-Ali H K; Radich J P; Maloney D G; Agura E; Bruno B; Epner E M; Chauncey T R; Blume K G; Niederwieser D; Sandmaier B M
Hematopoietic cell transplantation from HLA-identical sibling donors after low-dose radiation-based conditioning for treatment of CML.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2005;19(6):990-7.
2005: Mielcarek Marco; Burroughs Lauri; Leisenring Wendy; Diaconescu Razvan; Martin Paul J; Sandmaier Brenda M; Maloney David G; Maris Michael B; Chauncey Thomas R; Shizuru Judith A; Blume Karl G; Hegenbart Ute; Niederwieser Dietger; Forman Stephen; Bruno Benedetto; Woolfrey Ann; Storb Rainer
Prognostic relevance of 'early-onset' graft-versus-host disease following non-myeloablative haematopoietic cell transplantation.
British journal of haematology 2005;129(3):381-91.
2005: Baron F; Maris M B; Storer B E; Sandmaier B M; Panse J P; Chauncey T R; Sorror M; Little M-T; Maloney D G; Storb R; Heimfeld S
High doses of transplanted CD34+ cells are associated with rapid T-cell engraftment and lessened risk of graft rejection, but not more graft-versus-host disease after nonmyeloablative conditioning and unrelated hematopoietic cell transplantation.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2005;19(5):822-8.
2005: Chien Jason W; Maris Michael B; Sandmaier Brenda M; Maloney David G; Storb Rainer F; Clark Joan G
Comparison of lung function after myeloablative and 2 Gy of total body irradiation-based regimens for hematopoietic stem cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2005;11(4):288-96.
2005: Baron Frédéric; Maris Michael B; Storer Barry E; Sandmaier Brenda M; Stuart Monic J; McSweeney Peter A; Radich Jerald P; Pulsipher Michael A; Agura Edward D; Chauncey Thomas R; Maloney David G; Shizuru Judith A; Storb Rainer
HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative conditioning for patients with chronic myeloid leukemia.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2005;11(4):272-9.
2005: Baron Frédéric; Maris Michael B; Sandmaier Brenda M; Storer Barry E; Sorror Mohamed; Diaconescu Razvan; Woolfrey Ann E; Chauncey Thomas R; Flowers Mary E D; Mielcarek Marco; Maloney David G; Storb Rainer
Graft-versus-tumor effects after allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(9):1993-2003.
2005: Parikh Chirag R; Schrier Robert W; Storer Barry; Diaconescu Razvan; Sorror Mohamed L; Maris Michael B; Maloney David G; McSweeney Peter; Storb Rainer; Sandmaier Brenda M
Comparison of ARF after myeloablative and nonmyeloablative hematopoietic cell transplantation.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2005;45(3):502-9.
2005: Panse J P; Heimfeld S; Guthrie K A; Maris M B; Maloney D G; Baril B B; Little M-T; Chauncey T R; Storer B E; Storb R; Sandmaier B M
Allogeneic peripheral blood stem cell graft composition affects early T-cell chimaerism and later clinical outcomes after non-myeloablative conditioning.
British journal of haematology 2005;128(5):659-67.
2005: Kalina Tomas; Lu Hailing; Zhao Zhao; Blewett Earl; Dittmer Dirk P; Randolph-Habecker Julie; Maloney David G; Andrews Robert G; Kiem Hans-Peter; Storek Jan
De novo generation of CD4 T cells against viruses present in the host during immune reconstitution.
Blood 2005;105(6):2410-4.
2005: Maloney David G
Concepts in radiotherapy and immunotherapy: anti-CD20 mechanisms of action and targets.
Seminars in oncology 2005;32(1 Suppl 1):S19-26.
2005: Maloney David G
Treatment of follicular non-Hodgkin's lymphoma.
Current hematology reports 2005;4(1):39-45.
2005: Lu Hailing; Zhao Zhao; Kalina Tomas; Gillespy Thurman; Liggitt Denny; Andrews Robert G; Maloney David G; Kiem Hans-Peter; Storek Jan
Interleukin-7 improves reconstitution of antiviral CD4 T cells.
Clinical immunology (Orlando, Fla.) 2005;114(1):30-41.
2004: Storek Jan; Zhao Zhao; Lin Eugene; Berger Thomas; McSweeney Peter A; Nash Richard A; Akatsuka Yoshiki; Metcalf Monja D; Lu Hailing; Kalina Tomas; Reindl Markus; Storb Rainer; Hansen John A; Sullivan Keith M; Kraft George H; Furst Daniel E; Maloney David G
Recovery from and consequences of severe iatrogenic lymphopenia (induced to treat autoimmune diseases).
Clinical immunology (Orlando, Fla.) 2004;113(3):285-98.
2004: Maris Michael B; Sandmaier Brenda M; Storer Barry E; Chauncey Thomas; Stuart Monic Jain; Maziarz Richard T; Agura Edward; Langston Amelia A; Pulsipher Michael; Storb Rainer; Maloney David G
Allogeneic hematopoietic cell transplantation after fludarabine and 2 Gy total body irradiation for relapsed and refractory mantle cell lymphoma.
Blood 2004;104(12):3535-42.
2004: Baron Frédéric; Baker Jennifer E; Storb Rainer; Gooley Theodore A; Sandmaier Brenda M; Maris Michael B; Maloney David G; Heimfeld Shelly; Oparin Dmitrij; Zellmer Eustacia; Radich Jerald P; Grumet F Carl; Blume Karl G; Chauncey Thomas R; Little Marie-Térèse
Kinetics of engraftment in patients with hematologic malignancies given allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning.
Blood 2004;104(8):2254-62.
2004: Diaconescu Razvan; Flowers Christopher R; Storer Barry; Sorror Mohamed L; Maris Michael B; Maloney David G; Sandmaier Brenda M; Storb Rainer
Morbidity and mortality with nonmyeloablative compared with myeloablative conditioning before hematopoietic cell transplantation from HLA-matched related donors.
Blood 2004;104(5):1550-8.
2004: Sorror Mohamed L; Maris Michael B; Storer Barry; Sandmaier Brenda M; Diaconescu Razvan; Flowers Christopher; Maloney David G; Storb Rainer
Comparing morbidity and mortality of HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative and myeloablative conditioning: influence of pretransplantation comorbidities.
Blood 2004;104(4):961-8.
2004: Parikh Chirag R; Sandmaier Brenda M; Storb Rainer F; Blume Karl G; Sahebi Firoozeh; Maloney David G; Maris Michael B; Nieto Yago; Edelstein Charles L; Schrier Robert W; McSweeney Peter
Acute renal failure after nonmyeloablative hematopoietic cell transplantation.
Journal of the American Society of Nephrology : JASN 2004;15(7):1868-76.
2004: Storek J; Dawson M A; Lim L C-L; Burman B E; Stevens-Ayers T; Viganego F; Herremans M M P T; Flowers M E D; Witherspoon R P; Maloney D G; Boeckh M
Efficacy of donor vaccination before hematopoietic cell transplantation and recipient vaccination both before and early after transplantation.
Bone marrow transplantation 2004;33(3):337-46.
2004: Bethge Wolfgang A; Hegenbart Ute; Stuart Monic J; Storer Barry E; Maris Michael B; Flowers Mary E D; Maloney David G; Chauncey Thomas; Bruno Benedetto; Agura Ed; Forman Stephen J; Blume Karl G; Niederwieser Dietger; Storb Rainer; Sandmaier Brenda M
Adoptive immunotherapy with donor lymphocyte infusions after allogeneic hematopoietic cell transplantation following nonmyeloablative conditioning.
Blood 2004;103(3):790-5.
2004: Hogan William J; Maris Michael; Storer Barry; Sandmaier Brenda M; Maloney David G; Schoch H Gary; Woolfrey Ann E; Shulman Howard M; Storb Rainer; McDonald George B
Hepatic injury after nonmyeloablative conditioning followed by allogeneic hematopoietic cell transplantation: a study of 193 patients.
Blood 2004;103(1):78-84.
2003: Storek Jan; Dawson Monja A; Maloney David G
Correlation between the numbers of naive T cells infused with blood stem cell allografts and the counts of naive T cells after transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2003;9(12):781-4.
2003: Junghanss Christian; Storb Rainer; Maris Michael B; Carter Rachel A; Sandmaier Brenda M; Maloney David G; McSweeney Peter A; Corey Lawrence; Boeckh Michael
Impact of unrelated donor status on the incidence and outcome of cytomegalovirus infections after non-myeloablative allogeneic stem cell transplantation.
British journal of haematology 2003;123(4):662-70.
2003: Maloney David G; Molina Arthur J; Sahebi Firoozeh; Stockerl-Goldstein Keith E; Sandmaier Brenda M; Bensinger William; Storer Barry; Hegenbart Ute; Somlo George; Chauncey Thomas; Bruno Benedetto; Appelbaum Frederick R; Blume Karl G; Forman Stephen J; McSweeney Peter; Storb Rainer
Allografting with nonmyeloablative conditioning following cytoreductive autografts for the treatment of patients with multiple myeloma.
Blood 2003;102(9):3447-54.
2003: Bethge Wolfgang A; Storer Barry E; Maris Michael B; Flowers Mary E D; Maloney David G; Chauncey Thomas R; Woolfrey Ann E; Storb Rainer; Sandmaier Brenda M
Relapse or progression after hematopoietic cell transplantation using nonmyeloablative conditioning: effect of interventions on outcome.
Experimental hematology 2003;31(10):974-80.
2003: Gopal Ajay K; Gooley Theodore A; Maloney David G; Petersdorf Stephen H; Eary Janet F; Rajendran Joseph G; Bush Sharon A; Durack Lawrence D; Golden Jane; Martin Paul J; Matthews Dana C; Appelbaum Frederick R; Bernstein Irwin D; Press Oliver W
High-dose radioimmunotherapy versus conventional high-dose therapy and autologous hematopoietic stem cell transplantation for relapsed follicular non-Hodgkin lymphoma: a multivariable cohort analysis.
Blood 2003;102(7):2351-7.
2003: Press Oliver W; Unger Joseph M; Braziel Rita M; Maloney David G; Miller Thomas P; LeBlanc Michael; Gaynor Ellen R; Rivkin Saul E; Fisher Richard I
A phase 2 trial of CHOP chemotherapy followed by tositumomab/iodine I 131 tositumomab for previously untreated follicular non-Hodgkin lymphoma: Southwest Oncology Group Protocol S9911.
Blood 2003;102(5):1606-12.
2003: Fukuda Takahiro; Boeckh Michael; Carter Rachel A; Sandmaier Brenda M; Maris Michael B; Maloney David G; Martin Paul J; Storb Rainer F; Marr Kieren A
Risks and outcomes of invasive fungal infections in recipients of allogeneic hematopoietic stem cell transplants after nonmyeloablative conditioning.
Blood 2003;102(3):827-33.
2003: Mielcarek Marco; Martin Paul J; Leisenring Wendy; Flowers Mary E D; Maloney David G; Sandmaier Brenda M; Maris Michael B; Storb Rainer
Graft-versus-host disease after nonmyeloablative versus conventional hematopoietic stem cell transplantation.
Blood 2003;102(2):756-62.
2003: Storek Jan; Gillespy Thurman; Lu Hailing; Joseph Ansamma; Dawson Monja A; Gough Michael; Morris Julia; Hackman Robert C; Horn Peter A; Sale George E; Andrews Robert G; Maloney David G; Kiem Hans-Peter
Interleukin-7 improves CD4 T-cell reconstitution after autologous CD34 cell transplantation in monkeys.
Blood 2003;101(10):4209-18.
2003: Feinstein Lyle C; Sandmaier Brenda M; Maloney David G; Maris Michael B; Gooley Theodore A; Chauncey Thomas R; Hegenbart Ute; McSweeney Peter A; Stuart Monic J; Forman Stephen J; Agura Edward A; Pulsipher Michael A; Blume Karl G; Niederwieser Dietger W; Storb Rainer F
Allografting after nonmyeloablative conditioning as a treatment after a failed conventional hematopoietic cell transplant.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2003;9(4):266-72.
2003: Storek Jan; Viganego Federico; Dawson Monja A; Herremans M M P Tineke; Boeckh Michael; Flowers Mary E D; Storer Barry; Bensinger William I; Witherspoon Robert P; Maloney David G
Factors affecting antibody levels after allogeneic hematopoietic cell transplantation.
Blood 2003;101(8):3319-24.
2003: Maloney David G
Rituximab for follicular lymphoma.
Current hematology reports 2003;2(1):13-22.
2003: Feinstein Lyle C; Sandmaier Brenda M; Hegenbart Ute; McSweeney Peter A; Maloney David G; Gooley Theodore A; Maris Michael B; Chauncey Thomas R; Bruno Benedetto; Appelbaum Frederick R; Niederwieser Dietger W; Storb Rainer F
Non-myeloablative allografting from human leucocyte antigen-identical sibling donors for treatment of acute myeloid leukaemia in first complete remission.
British journal of haematology 2003;120(2):281-8.
2003: Maloney David G
Graft-vs.-lymphoma effect in various histologies of non-Hodgkin's lymphoma.
Leukemia & lymphoma 2003;44 Suppl 3():S99-105.
2002: Maciej Zaucha J; Mielcarek Marco; Takatu Alessandra; Little Marie-Terese; Gooley Theodore; Baker Jennifer; Maloney David G; Sandmaier Brenda M; Maris Michael; Chauncey Thomas; Storb Rainer; Torok-Storb Beverly
Engraftment of early erythroid progenitors is not delayed after non-myeloablative major ABO-incompatible haematopoietic stem cell transplantation.
British journal of haematology 2002;119(3):740-50.
2002: Rose Andrea L; Smith Barbara E; Maloney David G
Glucocorticoids and rituximab in vitro: synergistic direct antiproliferative and apoptotic effects.
Blood 2002;100(5):1765-73.
2002: Gopal Ajay K; Rajendran Joseph G; Petersdorf Stephen H; Maloney David G; Eary Janet F; Wood Brent L; Gooley Theodore A; Bush Sharon A; Durack Lawrence D; Martin Paul J; Matthews Dana C; Appelbaum Frederick R; Bernstein Irwin D; Press Oliver W
High-dose chemo-radioimmunotherapy with autologous stem cell support for relapsed mantle cell lymphoma.
Blood 2002;99(9):3158-62.
2002: Storek Jan; Joseph Ansamma; Dawson Monja A; Douek Daniel C; Storer Barry; Maloney David G
Factors influencing T-lymphopoiesis after allogeneic hematopoietic cell transplantation.
Transplantation 2002;73(7):1154-8.
2002: Mielcarek Marco; Sandmaier Brenda M; Maloney David G; Maris Michael; McSweeney Peter A; Woolfrey Ann; Chauncey Thomas; Feinstein Lyle; Niederwieser Dietger; Blume Karl G; Forman Stephen; Torok-Storb Beverly; Storb Rainer
Nonmyeloablative hematopoietic cell transplantation: status quo and future perspectives.
Journal of clinical immunology 2002;22(2):70-4.
2002: Storek Jan; Lalovic Bojan B; Rupert Kate; Dawson Monja A; Shen Danny D; Maloney David G
Kinetics of B, CD4 T, and CD8 T cells infused into humans: estimates of intravascular:extravascular ratios and total body counts.
Clinical immunology (Orlando, Fla.) 2002;102(3):249-57.
2002: Junghanss Christian; Boeckh Michael; Carter Rachel A; Sandmaier Brenda M; Maris Michael B; Maloney David G; Chauncey Thomas; McSweeney Peter A; Little Marie-Térèse; Corey Lawrence; Storb Rainer
Incidence and outcome of cytomegalovirus infections following nonmyeloablative compared with myeloablative allogeneic stem cell transplantation, a matched control study.
Blood 2002;99(6):1978-85.
2002: Maloney David G; Smith Barbara; Rose Andrea
Rituximab: mechanism of action and resistance.
Seminars in oncology 2002;29(1 Suppl 2):2-9.
2002: Linenberger Michael L; Maloney David G; Bernstein Irwin D
Antibody-directed therapies for hematological malignancies.
Trends in molecular medicine 2002;8(2):69-76.
2002: Maloney David G; Sandmaier Brenda M; Mackinnon Stephen; Shizuru Judith A
Non-myeloablative transplantation.
Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program 2002;():392-421.
2002: Junghanss Christian; Marr Kieren A; Carter Rachel A; Sandmaier Brenda M; Maris Michael B; Maloney David G; Chauncey Thomas; McSweeney Peter A; Storb Rainer
Incidence and outcome of bacterial and fungal infections following nonmyeloablative compared with myeloablative allogeneic hematopoietic stem cell transplantation: a matched control study.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2002;8(9):512-20.
2001: Weissinger F; Sandmaier B M; Maloney D G; Bensinger W I; Gooley T; Storb R
Decreased transfusion requirements for patients receiving nonmyeloablative compared with conventional peripheral blood stem cell transplants from HLA-identical siblings.
Blood 2001;98(13):3584-8.
2001: Storek J; Joseph A; Espino G; Dawson M A; Douek D C; Sullivan K M; Flowers M E; Martin P; Mathioudakis G; Nash R A; Storb R; Appelbaum F R; Maloney D G
Immunity of patients surviving 20 to 30 years after allogeneic or syngeneic bone marrow transplantation.
Blood 2001;98(13):3505-12.
2001: Gutierrez-Delgado F; Maloney D G; Press O W; Golden J; Holmberg L A; Maziarz R T; Hooper H; Buckner C D; Appelbaum F R; Bensinger W I
Autologous stem cell transplantation for non-Hodgkin's lymphoma: comparison of radiation-based and chemotherapy-only preparative regimens.
Bone marrow transplantation 2001;28(5):455-61.
2001: Maris M; Woolfrey A; McSweeney P A; Sandmaier B M; Nash R A; Georges G; Maloney D G; Molina A; Chauncey T; Yu C; Zaucha J M; Blume K G; Shizuru J; Niederwieser D; Storb R
Nonmyeloablative hematopoietic stem cell transplantation: transplantation for the 21st century.
Frontiers in bioscience : a journal and virtual library 2001;6():G13-6.
2001: Storek J; Wells D; Dawson M A; Storer B; Maloney D G
Factors influencing B lymphopoiesis after allogeneic hematopoietic cell transplantation.
Blood 2001;98(2):489-91.
2001: Maris M; Sandmaier B M; Maloney D G; McSweeney P A; Woolfrey A; Chauncey T; Shizuru J; Niederwieser D; Blume K G; Forman S; Storb R
Non-myeloablative hematopoietic stem cell transplantation.
Transfusion clinique et biologique : journal de la Société française de transfusion sanguine 2001;8(3):231-4.
2001: McSweeney P A; Niederwieser D; Shizuru J A; Sandmaier B M; Molina A J; Maloney D G; Chauncey T R; Gooley T A; Hegenbart U; Nash R A; Radich J; Wagner J L; Minor S; Appelbaum F R; Bensinger W I; Bryant E; Flowers M E; Georges G E; Grumet F C; Kiem H P; Torok-Storb B; Yu C; Blume K G; Storb R F
Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects.
Blood 2001;97(11):3390-400.
2001: Storek J; Dawson M A; Storer B; Stevens-Ayers T; Maloney D G; Marr K A; Witherspoon R P; Bensinger W; Flowers M E; Martin P; Storb R; Appelbaum F R; Boeckh M
Immune reconstitution after allogeneic marrow transplantation compared with blood stem cell transplantation.
Blood 2001;97(11):3380-9.
2001: Gopal A K; Gooley T A; Golden J B; Maloney D G; Bensinger W I; Petersdorf S H; Appelbaum F R; Press O W
Efficacy of high-dose therapy and autologous hematopoietic stem cell transplantation for non-Hodgkin's lymphoma in adults 60 years of age and older.
Bone marrow transplantation 2001;27(6):593-9.
2000: Storb R; McSweeney P A; Sandmaier B M; Nash R A; Georges G; Maloney D G; Molina A; Chauncey T; Yu C; Zaucha J M; Blume K G; Shizuru J; Niederwieser D
Allogeneic hematopoietic stem cell transplantation: from the nuclear age into the twenty-first century.
Transplantation proceedings 2000;32(7):2548-9.
2000: Storek J; Espino G; Dawson M A; Storer B; Flowers M E; Maloney D G
Low B-cell and monocyte counts on day 80 are associated with high infection rates between days 100 and 365 after allogeneic marrow transplantation.
Blood 2000;96(9):3290-3.
2000: Press O W; Eary J F; Gooley T; Gopal A K; Liu S; Rajendran J G; Maloney D G; Petersdorf S; Bush S A; Durack L D; Martin P J; Fisher D R; Wood B; Borrow J W; Porter B; Smith J P; Matthews D C; Appelbaum F R; Bernstein I D
A phase I/II trial of iodine-131-tositumomab (anti-CD20), etoposide, cyclophosphamide, and autologous stem cell transplantation for relapsed B-cell lymphomas.
Blood 2000;96(9):2934-42.
2000: Storek J; Dawson M A; Maloney D G
Normal T, B, and NK cell counts in healthy donors at 1 year after blood stem cell harvesting.
Blood 2000;95(9):2993-4.
1999: Holmberg L A; Boeckh M; Hooper H; Leisenring W; Rowley S; Heimfeld S; Press O; Maloney D G; McSweeney P; Corey L; Maziarz R T; Appelbaum F R; Bensinger W
Increased incidence of cytomegalovirus disease after autologous CD34-selected peripheral blood stem cell transplantation.
Blood 1999;94(12):4029-35.
1999: Maloney D G
Preclinical and phase I and II trials of rituximab.
Seminars in oncology 1999;26(5 Suppl 14):74-8.
1999: Maloney D G
Advances in the immunotherapy of hematologic malignancies: cellular and humoral approaches.
Current opinion in hematology 1999;6(4):222-8.
1999: Maloney D G; Donovan K; Hamblin T J
Antibody therapy for treatment of multiple myeloma.
Seminars in hematology 1999;36(1 Suppl 3):30-3.
1998: Maloney D G; Press O W
Newer treatments for non-Hodgkin's lymphoma: monoclonal antibodies.
Oncology (Williston Park, N.Y.) 1998;12(10 Suppl 8):63-76.
1998: Liu S Y; Eary J F; Petersdorf S H; Martin P J; Maloney D G; Appelbaum F R; Matthews D C; Bush S A; Durack L D; Fisher D R; Gooley T A; Bernstein I D; Press O W
Follow-up of relapsed B-cell lymphoma patients treated with iodine-131-labeled anti-CD20 antibody and autologous stem-cell rescue.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(10):3270-8.
1998: Storek J; Dawson M A; Maloney D G
Comparison of two flow cytometric methods enumerating CD4 T cells and CD8 T cells.
Cytometry 1998;33(1):76-82.
1998: Maloney D G
Advances in immunotherapy of hematologic malignancies.
Current opinion in hematology 1998;5(4):237-43.
1997: Schiffman K; Buckner C D; Maziarz R; Maloney D G; Appelbaum F R; Press O; Gooley T; Holmberg L; Lilleby K; Clift R; Zuckerman N; Klarnet J; Weaver C; Chauncey T; Bensinger W I
High-dose busulfan, melphalan, and thiotepa followed by autologous peripheral blood stem cell transplantation in patients with aggressive lymphoma or relapsed Hodgkin's disease.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 1997;3(5):261-6.
1996: Bensinger W I; Rowley S D; Demirer T; Lilleby K; Schiffman K; Clift R A; Appelbaum F R; Fefer A; Barnett T; Storb R; Chauncey T; Maziarz R T; Klarnet J; McSweeney P; Holmberg L; Maloney D G; Weaver C H; Buckner C D
High-dose therapy followed by autologous hematopoietic stem-cell infusion for patients with multiple myeloma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(5):1447-56.
1995: Maloney D G
Non-Hodgkin's lymphoma.
Current opinion in hematology 1995;2(4):255-61.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

David Maloney

Research Profile (preview)

Procedures

Disorders

Concepts & Ideas

Chemicals & Drugs

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of David Maloney (preview)

All Publications